ArticlePharmaceutics2022

Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics.

Michel Siegel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.